BSN antisense RNA 1 (BSN-AS1)

BSN antisense RNA 1 (BSN-AS1) is a long noncoding RNA transcribed from the antisense strand of the BSN gene locus. Like other antisense RNAs, BSN-AS1 may have regulatory roles in gene expression at the level of transcription, mRNA stability, or chromatin remodeling, yet its specific biological activities and relevance in disease remain poorly characterized. Antisense RNAs overall have emerged as important modulators of epigenetic regulation and potential contributors to cancer or other diseases, mostly through epigenetic silencing or activation pathways, but direct functional or therapeutic evidence for BSN-AS1 is lacking. Note: The principal challenge with BSN-AS1 is a lack of sufficient scientific literature confirming it as a druggable or disease-associated therapeutic target. It should primarily be considered a long noncoding antisense RNA of regulatory relevance. Most functional and disease associations described above are inferred from the wider class of antisense RNAs rather than directly established for BSN-AS1.

Other names

BSN antisense transcript 1long noncoding RNA BSN-AS1

Not applicable—no approved drugs targeting BSN-AS1. Mechanisms for antisense RNA drug targeting typically include hybridization and RNase H-mediated degradation, but these are not established for BSN-AS1 itself.